Impath denies Internet rumours:
This article was originally published in Clinica
New York-based Impath has denied anonymous claims made on the Internet that it is the subject of an investigation by the US Securities and Exchange Commission. The company stresses that the "fundamentals of its business continue to remain strong". Impath is a source of cancer information and analyses and has a 350,000-case cancer database.